DGX vs XPEL · P/E 22, rev $5.94B vs P/E 24, rev $260.4M
Quest Diagnostics Incorporated (DGX) versus Xpel Inc (XPEL) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Xpel Inc (XPEL) is a auto parts company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported XPEL revenue for 2026-06-30 was $260.4M. Net income was $28.4M. XPEL currently screens at market cap $1.25B and trailing P/E 23.7.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. XPEL currently screens at market cap $1.25B and trailing P/E 23.7.
Not investment advice. Open the DGX and XPEL stock pages for the full models.
Not investment advice.